Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism Case report

被引:7
作者
Abdulaziz, Ammar Taha Abdullah [1 ]
Yu, Xiao Qing [1 ]
Zhang, Le [1 ]
Jiang, Xin Yue [1 ]
Zhou, Dong [1 ]
Li, Jin Mei [1 ]
机构
[1] Sichuan Univ, West China Hosp, 37 Guo Xue Xiang St, Chengdu 610041, Sichuan, Peoples R China
关键词
anti-yo antibody; breast cancer; hypermetabolism; paraneoplastic cerebellar degeneration; NEUROLOGICAL SYNDROMES; ANTIBODIES; DISORDERS; PET/CT;
D O I
10.1097/MD.0000000000010717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Paraneoplastic cerebellar degeneration (PCD) is an immune-mediated neurological deficit affecting the cerebellum. AntiYo antibody positive PCD is a rare occurrence most likely associated with gynecologic or breast malignancies. The identification of the underlying tumor is a diagnostic challenge in many of these patients. Patientconcerns: We present a 68-year-old woman with acute symptoms of PCD as a first sign of underlying occult malignancy. Further investigation revealed a positive anti-Yo antibody. Although brain magnetic resonance imaging (MRI) was unremarkable, positron emission tomography (PET)/computed tomography (CT) revealed intense hypermetabolism of cerebellum and diffused hypometabolism in the rest of brain. On 1-year follow-up, despite the primary malignancy is still unknown, her symptoms improved significantly after immunotherapy. Diagnoses: Paraneoplastic cerebellar degeneration. Interventions: The patient was given IV methylprednisolone 500mg once a day for 5 consecutive days, followed by oral prednisone 60mg once a day for 3months. Outcomes: The patient's symptoms were gradually improved during the hospitalization period. On one year follow up, she was able to walk independently and perform some simple tasks. Lessons: Cerebellar hypermetabolism in PCD suspected patients may help confirming the diagnosis in an earlier stage and may predict a better outcome after immunotherapy.
引用
收藏
页数:5
相关论文
共 15 条
[1]   Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration [J].
Choi, KD ;
Kim, JS ;
Park, SH ;
Kim, YK ;
Kim, SE ;
Smitt, PS .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (04) :525-528
[2]   Paraneoplastic syndromes of the CNS [J].
Dalmau, Josep ;
Rosenfeld, Myrna R. .
LANCET NEUROLOGY, 2008, 7 (04) :327-340
[3]   Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration [J].
Finsterer, Josef ;
Voigtlaender, Till ;
Grisold, Wolfgang .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 308 (1-2) :139-141
[4]  
Gheysens Olivier, 2014, Br J Haematol, V164, P468, DOI 10.1111/bjh.12619
[5]   Navigating the paraneoplastic neurological syndromes [J].
Giannopoulou, C .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (03) :333-338
[6]  
Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447
[7]   Treatment of Paraneoplastic Neurologic Disorders [J].
Greenlee, John E. .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (03) :212-230
[8]   Immunological features of paraneoplastic neurological syndromes [J].
Lorusso, L ;
Hart, IK ;
Giometto, B ;
Pezzani, R ;
Broome, JC ;
Gritti, D ;
Gasparetto, C ;
Ricevuti, G .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2004, 17 (02) :135-144
[9]   Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies [J].
Lucchinetti, CF ;
Kimmel, DW ;
Lennon, VA .
NEUROLOGY, 1998, 50 (03) :652-657
[10]   PARANEOPLASTIC CEREBELLAR DEGENERATION .1. A CLINICAL ANALYSIS OF 55-ANTI-YO ANTIBODY-POSITIVE PATIENTS [J].
PETERSON, K ;
ROSENBLUM, MK ;
KOTANIDES, H ;
POSNER, JB .
NEUROLOGY, 1992, 42 (10) :1931-1937